Topics
Latest
AI
Amazon
Image Credits:Harrison.ai
Apps
Biotech & Health
mood
Image Credits:Harrison.ai
Cloud Computing
Department of Commerce
Crypto
Enterprise
EVs
Fintech
fund-raise
gismo
Gaming
Government & Policy
Hardware
Layoffs
Media & Entertainment
Meta
Microsoft
Privacy
Robotics
Security
Social
Space
Startups
TikTok
Transportation
Venture
More from TechCrunch
Events
Startup Battlefield
StrictlyVC
Podcasts
Videos
Partner Content
TechCrunch Brand Studio
Crunchboard
meet Us
Medical tomography is all important for the well-timed identification of serious diseases like cancer . However , manual interpretation of CAT scan is a time - intensive physical process . Healthcare pro increasingly use AI - powered tools for diagnostic purposes , as such technologies can be very effective in detecting and categorizing diseases .
A Sydney , Australia - headquartered inauguration , Harrison.ai , has built AI - enable aesculapian diagnostic software and services to examine CT scan , X - rays , and pathology slide for radiologists and medical tester . On Tuesday , the startup said it ’s put up $ 112 million , tantamount to AU$179 million , in Series C financing , to descale its outside reach in key markets , including the U.S. , EMEA , and Asia Pacific . It declined comment on its rating when asked .
Aware Super , ECP Asset Management , and Horizons Ventures co - led the funding round along with new investors , include the National Reconstruction Fund , Ord Minnett , and Wollemi Capital Group , as well as retrovert investor such as Alpha JWC Ventures and Blackbird Ventures .
Harrison.ai offers two dissimilar production : symptomatic software system that ’s focused on radiology , calledAnnalise.ai , and a pathology - concentrate offer , Franklin.ai . Both have the overarching goal of avail clinician name medical conditions more accurately and efficiently . The inauguration believes the AI instrument can aid in the early signal detection of medical conditions , expedite handling conclusion , and reduce wait clip for patients .
“A second pair of eyes”
“ Radiology ( X - electron beam , CT scans ) and pathology ( tissue paper biopsies ) serve as decisive diagnostic tools for confirm aesculapian diagnosis , ” Dr. Aengus Tran , Harrison.ai ’s CEO and atomic number 27 - founder , allege in an exclusive interview with TechCrunch . “ [ Harrison ’s ] solution also act as a 2d brace of centre for radiotherapist and pathologists , enhancing workflow efficiency while reducing misdiagnosis risks for cancer and other decisive illnesses – ultimately improving patient outcomes . ”
The startup wants its technology to help oneself addressthe world-wide shortageofskilledcliniciansand the billow in demand for diagnosis that ’s affect both developed and developing health care systems .
Harrison.ai was founded in 2018 by brothers Dr. Aengus Tran and Dimitry Tran , who grew up in Vietnam before moving to Australia . Aengus , a Doctor of the Church trained in Sydney , saw firsthand the capacity constraints in diagnosis and intervention that led to poor outcomes for patient . Dimitry and Aengus teamed up to produce Harrison.ai , using their several experience in healthcare scheme and medical / AI expertness with the goal of hike up healthcare capacity through AI mechanization .
Join us at TechCrunch Sessions: AI
Exhibit at TechCrunch Sessions: AI
The startup ’s late financing , which bring Harrison.ai ’s total raised to $ 240 million , get roughly three years after itsSeries B round(approximately $ 92.3 million , back in November 2021 ) .
Since its Series B , the inauguration has found Franklin.ai , its pathology solution , while its first production in prostate gland biopsy is in maturation and will be available in 2025 , per Tran .
It began monetizing Annalise.ai back in 2022 and has tripled contract annual fall back revenue each twelvemonth for the past three consecutive years for the radiology offering , he added . Annalise.ai is currently operational in more than 1,000 healthcare facilities in various state , affirm the treatment of over 6 million patients each year .
The inauguration , which now has roughly 200 employees , has expanded beyond Australia and now operates in 15 countries , including the U.K. , U.S. , Italy , Germany , Spain , UAE , New Zealand , Singapore , India , Malaysia , and Vietnam . It has regulative clearance for clinical manipulation in 40 countries , include 12 FDA headroom in the U.S. , and plans to set up a North American presence in Boston this class .
“ We have a distinctive software package taxation model — standardized to many SaaS companies — making it simple for our client to buy and deploy for function in clinical pattern , ” said Harrison.ai ’s CEO .
Competition
There are an regalia of players in the space , including the likes ofAidoc , Gleamer , Rad AIandZebra . But Tran argues it ’s been able to set itself apart from competitors since its Chest X - ray ware has gained regulative headroom across 40 countries for the spotting of up to 124 finding , which it sound out is about 4x what rivals can do .
The startup also claim that research read Harrison ’s AI for chest radiography can help observe lung Crab earlier , potentially diagnosing more than 32 % of cases 16 months sooner . ( This information is based on a subject field conducted by the Asian Institute for Distance Education at healthcare supplier Alfred Health in 2024 . )
likewise , its CT Brain product has obtained regulatory headway for the detection of up to 130 findings — again , a bit that ’s approximately 4x majuscule than that of competitor , agree to Tran .
“ This is made possible through our access to extensive datasets which have been finely - tuned by more than 250 specialist doctor , over more than 240,000 hours , ” he say , adding that the inauguration will be using some of the new financial support to build out even more AI automation across more symptomatic run other than radiology and pathology .
Last year , the company launched Harrions.rad.1 , a radioscopy - specific sight - language model that can answer open - end visual question about radiology mental image , detect findings , and ply description . This model , which is not commercially useable — but is accessible to researchers , diligence partners , and regulator – exponent the startup ’s products and outgo other foundational models , as well as standard radioscopy scrutiny bear by human radiologist , according to the company .
